# Pregabalin for the Treatment and Prevention of Spinal Cord Injury Neuropathic Pain

> **NCT01479556** · PHASE4 · UNKNOWN · sponsor: **Julian Taylor Green** · enrollment: 82 (estimated)

## Conditions studied

- Neuropathic Pain
- Spinal Cord Injuries

## Interventions

- **DRUG:** Pregabalin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01479556
- **Lead sponsor:** Julian Taylor Green
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-12
- **Primary completion:** 2014-05
- **Final completion:** 2014-10
- **Target enrollment:** 82 (ESTIMATED)
- **Last updated:** 2011-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01479556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01479556, "Pregabalin for the Treatment and Prevention of Spinal Cord Injury Neuropathic Pain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01479556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*